Live tape
Top 8, mentions 7d17,305MSFT3,274 mentions▲ +0.08GOOGL2,648 mentions▲ +0.05META2,209 mentions▲ +0.04AAPL2,204 mentions▲ +0.07SPCX1,987 mentions▲ +0.06SNDK1,823 mentions▲ +0.06NVDA1,742 mentions▲ +0.07QQQ1,418 mentions▲ +0.04

Equity · Healthcare

RYTM

Rhythm Pharmaceuticals, Inc. · NasdaqGM

$107.00 +0.94% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart Chart by TradingView

The chart above plots the price of RYTM over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 56 sessions over that window: $82.00 on 1 May 2026 through $107.00 on 17 July 2026. Finazon · prior-day close.

Market cap $7.3B
52-week range $75.84 – $118.00
Avg volume 256.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

RYTM insider trades

SEC Form 4

RYTM has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 11 December 2025.

Date Insider Type Shares Value
11 Dec 2025 Cramer Pamela J. Chief Human Resources Officer Sell 3,350 $372K
20 Nov 2025 Cramer Pamela J. Chief Human Resources Officer Sell 3,350 $352K
10 Nov 2025 Cramer Pamela J. Chief Human Resources Officer Sell 3,515 $352K
07 Nov 2025 Cramer Pamela J. Chief Human Resources Officer Sell 19,351 $1.91M
30 Oct 2025 Shulman Joseph Chief Technical Officer Sell 9,748 $1.12M
28 Oct 2025 Shulman Joseph Chief Technical Officer Sell 2,815 $324K

Showing the 12 most recent of 39 filings in this window. The figures above count all of them.

Compensation mechanics (6 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
11 Dec 2025 Cramer Pamela J. Chief Human Resources Officer Option exercise 3,350 $92K
20 Nov 2025 Cramer Pamela J. Chief Human Resources Officer Option exercise 3,350 $92K
10 Nov 2025 Cramer Pamela J. Chief Human Resources Officer Option exercise 3,515 $24K
07 Nov 2025 Cramer Pamela J. Chief Human Resources Officer Option exercise 19,351 $239K
30 Oct 2025 Shulman Joseph Chief Technical Officer Option exercise 9,748 $299K
28 Oct 2025 Shulman Joseph Chief Technical Officer Option exercise 2,815 $79K

RYTM reported financials

SEC EDGAR XBRL

RYTM reported revenue of $189.8M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$196.5M.

Figure Reported Period
Revenue $189.8M 31 Dec 2025 fiscal year
Net income −$196.5M 31 Dec 2025 fiscal year
Diluted EPS −$3.11 31 Dec 2025 fiscal year
Total assets $442.3M 31 Mar 2026 at period end
Total equity $122.9M 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

RYTM earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-0.83
31 Dec 2025 FY 2025 $-3.11
30 Sep 2025 Q3 2025 $-0.82
30 Jun 2025 Q2 2025 $-0.75

Reported figures & scheduled dates · SEC EDGAR filings

RYTM institutional holders

SEC Form 13F

12 of the 45 institutional funds we track reported a RYTM position for the quarter ended 31 Mar 2026 — a combined $762.1M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) 5,604,483 $487.4M
Citadel Advisors Added +825.3% shares 1,418,619 $123.4M
Point72 Asset Management Added +97.2% shares 846,801 $73.6M
Millennium Management Added +142.0% shares 451,825 $39.3M
Renaissance Technologies Held (±25%) −24.4% shares 258,011 $22.4M
AQR Capital Management Held (±25%) −15.4% shares 59,279 $5.2M
Balyasny Asset Management Trimmed −26.7% shares 52,967 $4.6M
D. E. Shaw & Co. Held (±25%) +4.1% shares 32,652 $2.8M
Tudor Investment Corp New position 19,646 $1.7M
Marshall Wace New position 9,628 $837K

Source: SEC EDGAR 13F filings

RYTM fails-to-deliver

SEC CNS data

On 29 Jun 2026, 22,261 shares of RYTM failed to deliver (about $2.4M).

Settlement date Shares failed Notional % of shares out
29 Jun 2026 22,261 $2.4M 0.032%
24 Jun 2026 160 $17K <0.001%
22 Jun 2026 9 $871 <0.001%
18 Jun 2026 23 $2K <0.001%
16 Jun 2026 242 $22K <0.001%
15 Jun 2026 23 $2K <0.001%

Source: SEC fails-to-deliver (CNS) data